hVIVO plc (formerly Open Orphan plc)
Company Profile
Company website
Sector
Health Care Providers (Health Care Services)
Description
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
10
Apr
Event information
The Company will announce its final results for the year ended 31 December 2024 on 10 April 2025.
The Company will host an Investor Meet Company presentation at 6pm on 10 April 2025. Investors can sign up to Investor Meet Company for free and add to meet hVIVO here.Venue
Online
Time
6pm on 10 April 2025
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | May |
* Months based on previous announcements of this kind
